1. Published

   Cost of non-compliance and non-persistence with medications for diabetes mellitus

   Hughes, D., Salas, M., Hughes, D. A., Lebmeier, M. & Vardeva, K., 1 Aug 2007.

   Research output: Contribution to conference › Paper

2. Published

   Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity

   Hughes, D., Hughes, D. A., Vilar, F. J., Ward, C. C., Alfirevic, A., Park, B. K. & Pirmohamed, M., 1 Jun 2004, In: Pharmacogenetics. 14, 6, p. 335-342

   Research output: Contribution to journal › Article › peer-review

3. Published

   Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.

   Hughes, D., Hughes, D. A. & Dubois, D., 1 Jan 2004, In: Pharmacoeconomics. 22, 16, p. 1047-1059

   Research output: Contribution to journal › Article › peer-review

4. Published

   Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.

   Hughes, D., Hughes, D. A., Bodger, K. & Kikuchi, T., 1 Apr 2008.

   Research output: Contribution to conference › Paper

5. Published

   Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.

   Hughes, D., Hughes, D. A., Bodger, K. & Kikuchi, T., 1 Apr 2008.

   Research output: Contribution to conference › Paper

6. Published

   Cost-effectiveness considerations in pharmacogenetics.

   Hughes, D. & Hughes, D. A., 1 Jan 2008.

   Research output: Contribution to conference › Paper

7. Published

   Cost-effectiveness findings from the Agewell pilot study of behaviour change to promote health and wellbeing in later life

   Jones, C. L., Edwards, R. T., Nelis, S. M., Jones, I. R., Hindle, J. V., Thom, J. M., Cooney, J. & Clare, L., 8 Dec 2015, In: Health Economics and Outcome Research: Open Access. 1, 1

   Research output: Contribution to journal › Article › peer-review

8. Published

   Cost-effectiveness of a national exercise referral programme for primary care patients in Wales: results of a randomised controlled trial

   Linck, P. G., Williams, N. H., Edwards, R. T., Linck, P., Hounsome, N., Raisanen, L., Williams, N., Moore, L. & Murphy, S., 29 Oct 2013, In: BMC Public Health. 13, p. 1021

   Research output: Contribution to journal › Article › peer-review

9. Published

   Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data.

   Hughes, D., Bodger, K., Kikuchi, T. & Hughes, D. A., 1 Aug 2009, In: Alimentary Pharmacology and Therapeutics. 30, 3, p. 265-274

   Research output: Contribution to journal › Article › peer-review

10. Published

    Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy

    Plumpton, C., Yip, V. L. M., Alfirevic, A., Marson, A. G., Pirmohamed, M. & Hughes, D., Apr 2015, In: Epilepsia.

    Research output: Contribution to journal › Article › peer-review